Scrip Reports has released a new business report entitled RNAi: The Revolution in Drug Discovery, which includes a review and analysis of the gene silencing technology.
According to Scrip, the report addresses such issues as the advantages of using RNAi in drug discovery, the major industry players, how the technology compares to antisense, and the importance of off-target effects.
Details on obtaining the report can be found at pjbpubs.com/cms.asp?pageid=1393.